Analytical Method Development and Validation of Assay for Carvedilol Tablets by RP-HPLC, HPTLC and UV Spectroscopy by Nisha, P J
ANALYTICAL METHOD DEVELOPMENT AND VALIDATION OF ASSAY FOR 
CARVEDILOL TABLETS BY RP-HPLC, HPTLC AND UV SPECTROSCOPY 
 
 Dissertation work submitted to 
The TamilNadu Dr. M.G.R. Medical University, Chennai 
in partial fulfillment for the award of degree of 
 
MASTER OF PHARMACY 
IN 
PHARMACEUTICAL ANALYSIS 
Submitted by 
NISHA.P.J 
Reg No. 26106425 
 
Under the Guidance of 
         Institutional Guide      Industrial Guide 
Mr.P.KUMAR NALLASIVAN, M.Pharm, (Ph.D)        Mr. SHAIK MOHAMMED NOOR, 
Assistant Professor,      Senior Manager, 
Department of Pharmaceutical Analysis,   Shasun Pharmaceuticals Ltd, 
RVS College of Pharmaceutical Sciences,    Puducherry. 
Sulur, Coimbatore.                                                    
 
                                                                                                                              
 
                                                        
 
 
                              DEPARTMENT OF PHARMACEUTICAL ANALYSIS 
R V S COLLEGE OF PHARMACEUTICAL SCIENCES 
SULUR, COIMBATORE – 641402 
TAMILNADU. 
MAY 2012 
 
CERTIFICATE 
 
This is to certify that the dissertation work entitled “ANALYTICAL METHOD 
DEVELOPMENT AND VALIDATION OF ASSAY  FOR CARVEDILOL TABLETS BY 
RP-HPLC, HPTLC AND UV SPECTROSCOPY” is a bonafide work of  Ms. NISHA P.J 
carried  out  in SHASUN PHARMACEUTICALS LIMITED, PUDUCHERRY under my 
guidance and under the supervision of Mr. SHAIK MOHAMMED NOOR and has completed to 
my fullest satisfaction for  partial fulfillment of the award of degree of Master of Pharmacy in 
Pharmaceutical Analysis, R V S  college of Pharmaceutical Sciences, Sulur, Coimbatore, which 
is affiliated to The Tamilnadu Dr. M.G.R Medical University, Chennai. It is to certify that the 
part or whole of the work has not been submitted either to this university or any other university. 
This work is original and confidential. 
 
 
 
 
 
                                                           INSTITUTIONAL GUIDE 
                                                           Mr. P.KUMAR NALLASIVAN, M.Pharm.,(Ph.D.) 
                                                           Assistant Professor, 
                                                           Department of Pharmaceutical Analysis, 
                                                           R.V.S College of Pharmaceutical Sciences, 
                                                           Sulur, Coimbatore-641402. 
Date: 
Place: 
 
 CERTIFICATE 
 
This is to certify that the dissertation work entitled “ANALYTICAL METHOD 
DEVELOPMENT AND VALIDATION OF ASSAY FOR CARVEDILOL TABLETS BY 
RP-HPLC, HPTLC AND UV SPECTROSCOPY” is a bonafide research work done by Ms. 
NISHA.P.J carried out in SHASUN PHARMACEUTICALS LIMITED,PUDUCHERRY under 
the guidance of Mr. P.KUMAR NALLASIVAN, M. Pharm.,(Ph.D.),Assistant Professor, RVS 
College of pharmaceutical science, Sulur  and Mr. SHAIK MOHAMMED NOOR, Senior 
Manager, Shasun pharmaceuticals,  for partial fulfillment of the requirement for the award of 
Master of Pharmacy in Pharmaceutical Analysis, R V S  college of Pharmaceutical Sciences, 
Sulur, Coimbatore, which is affiliated to The Tamilnadu Dr. M.G.R Medical University, 
Chennai.  
 
 
 
 
                                                   
                                                    
 Dr. R.VENKATA NARAYANAN, M. Pharm., Ph. D 
                                                PRINCIPAL, 
                                                R.V.S College of Pharmaceutical Sciences, 
                                                Sulur, Coimbatore-641402. 
Date: 
Place: 
 
 
 CERTIFICATE 
 
This is to certify that the dissertation work entitled “ANALYTICAL METHOD 
DEVELOPMENT AND VALIDATION OF ASSAY FOR CARVEDILOL TABLETS BY 
RP-HPLC, HPTLC AND UV SPECTROSCOPY” is a bonafide research work done by Ms. 
NISHA.P.J carried out in SHASUN PHARMACEUTICALS LIMITED, PUDUCHERRY under 
the guidance of Mr. P.KUMAR NALLASIVAN. M. Pharm.,(Ph.D.),Assistant Professor, RVS 
College of pharmaceutical science, Sulur   and Mr. SHAIK MOHAMMED NOOR, Senior 
Manager, Shasun Pharmaceuticals for partial fulfillment of the requirement for the award of 
Master of Pharmacy in Pharmaceutical Analysis, R V S  college of Pharmaceutical Sciences, 
Sulur, Coimbatore, which is affiliated to The Tamilnadu Dr. M.G.R Medical University, 
Chennai.  
 
 
 
  
                                                     
   Dr. W.D.SAM SOLOMON, M. Pharm., Ph. D 
                                                  Professor and Head,  
                                                         Department of Pharmaceutical Analysis, 
                                                             R.V.S College of Pharmaceutical Sciences, 
                                                  Sulur, Coimbatore-641402. 
Date: 
Place: 
 
 
  
 
CERTIFICATE 
 
This is to certify that the dissertation work entitled “ANALYTICAL METHOD 
DEVELOPMENT AND VALIDATION OF ASSAY FOR CARVEDILOL TABLETS BY 
RP-HPLC, HPTLC AND UV SPECTROSCOPY” is a bonafide research work done in 
ORCHID HEALTHCARE, CHENNAI by Ms. NISHA.P.J in partial fulfillment of the 
requirement for the award of Master of Pharmacy in Pharmaceutical Analysis, R V S college 
of Pharmaceutical Sciences, Sulur, Coimbatore,. under the supervision and guidance of Mr. 
P.KUMARNALLASIVAN. M.Pharm, (Ph.D.), Assistant Professor, Department of 
Pharmaceutical Analysis, RVS College of pharmaceutical science Sulur and Mr. SHAIK 
MOHAMMED NOOR, Senior Manager, Quality Control Department, Shasun Pharmaceuticals, 
Puducherry. 
 
 
 
 
INTERNAL EXAMINER                                                    EXTERNAL EXAMINER                               
  
Place:                                                                                      Place:                                                             
 Date:                                                                                       Date: 
                                                     
   
 
                                           ACKNOWLEDGEMENT 
 
First and foremost I thank ALMIGHTY GOD for my successful completion of this work. This 
book which has turned into a reality due to the blessings and prayers of a lot of people, whom 
I am really grateful to, 
 
It gives me immense pleasure to convey my deep sense of gratitude and heartfelt thanks to my
guide Mr. P. Kumarnallasivan M. Pharm., Assistant Professor, Department of
Pharmaceutical Analysis, RVS college of Pharmaceutical Sciences, Sulur, Coimbatore for his
help, motivation, suggestions, guidance, encouragement and the confidence that he has
shown in me throughout the course of my work. 
 
I sincerely thank Dr. R. Venkatanarayanan, Professor and Principal, RVS college of
Pharmaceutical Sciences, Sulur, Coimbatore, for his inspirations and for being a great
facilitator. 
 I am extremely grateful to Mr. Shaik Mohammed Noor (Senior Manager-QC),
Mr. Balu (Asst.Manager- QC) Shasun Pharmaceutical limited Puducherry, for his invigorate
guidance, felicitous advice, valuable hints with energizing criticism throughout the course of
this dissertation work.  
I would like to acknowledge the help rendered by the team of method development and
validation group under Mr. K. Rajagopal , J.N. Satheesh, and Mr. G. Ratha Krishna Reddy.
Analytical research and Development, shasun pharmaceutical for providing the timely
suggestions.  
I express my sincere gratitude to my teachers Mr. Sam Solomon, Mr. Sivakumar, 
 Mr. Vijayaanand for their meticulous guidance and encouragement provided to me for the
completion of my dissertation work.  
 
I really grateful to Dalmia Research Centre Coimbatore for providing all the facilities for
doing my HPTLC work. 
 My precious thanks to my shasun precious seniors Ms. Saiprabha, Mr. Prabhu,                        
Mr. Ramakrishnan, Mr. Karthick, Mr. Gunasekaran, Mr. Venkateshan are also and entitled to 
my profuse gratitude.  
I thank Mr. Sendhurpandi, Librarian, Mr. Kannan, Mrs. Stella Mary and Mr. Mohan, Asst. 
Librarian, RVS college of Pharmaceutical Sciences, Sulur, Coimbatore for providing me library 
facilities.  
 
My heartfelt thanks to my friends Dibin, Deepika, Muthuvadivel, Parimaleswari, Pulla Reddy, 
Rajeswari, Suresh, S.Beetha Rohini Sr. Akshaya. CSS for their support, honest opinions and 
diligence kept me lively. 
 
Above all I dedicate myself before the constant love and encouragement given to me by my 
Congregation of Sisters of Charity, my Parents, Brother and dear ones, who deserves the credit 
of success in whatever work I do. 
  
 
 
 
 
 
 
Date:              NISHA P J 
Place: Coimbatore                                                                    (Reg.No.26106425) 
                 
 
                    
 
 
 
                 
 
 
 
ABBREVIATIONS 
ACN  : Acetonitrile 
g  : gram 
HPLC  : High performance liquid chromatography 
pH               :            Hydrogen ion concentration 
ICH  : International conference on harmonization 
mg  : Milligram 
ml               :           Milliliter 
µg  : Microgram 
µg/ml           :            Microgram per milliliter 
µg                :           Microgram 
nm  : Nanometer 
PA  : Purity Angle 
PDA  : Photo diode array 
TH  : Purity threshold 
RSD  : Relative standard deviation 
k  : Retention time 
SD  : Standard deviation 
UV               :          Ultra violet 
V/v             :         Volume by Volume 
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                                                         INTRODUCTION  
Quality can be defined as the character, which defines the grade of excellence. A good 
quality drug is something, which will meet the established product specifications, can be 
safely bought and confidently used for the purpose for which it is intended.1 To get a good 
quality   drug ,the manufacturing  for making a drug should have quality built into it. 
Analytical chemistry is the science that seeks ever improved means of measuring the 
chemical composition of natural and artificial materials. Analytical chemistry is a sub-
discipline of chemistry that has the broad mission of understanding the chemical composition 
of all matter and developing the tools to elucidate such compositions.2 
TYPES: 
Traditionally, analytical chemistry has been split into two main types, qualitative and 
quantitative. 
QUALITATIVE: 
Qualitative analysis seeks to establish the presence of a given element, given functional group 
or inorganic or organic compound in a sample. 
QUANTITATIVE: 
Quantitative analysis seeks to establish the amount of a given element or compound in a 
sample. 
MODERN ANALYTICAL CHEMISTRY: 
Modern analytical chemistry is dominated by instrumental analysis. There are so many 
different types of instruments today that it can seem like a confusing array of acronyms rather 
than a unified field of study. Most modern analytical chemistry is categorized by different 
analytical methods. 
Analytical methods:- 
• Spectrophotometry and colorimetry. 
       UV-visible spectroscopy. 
• Chromatography and Electrophoresis. 
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Commonly used methods are, 
• High Performance Liquid Chromatography (HPLC). 
• High Performance Thin Layer Chromatography (HPTLC). 
• Gas chromatography (GC). 
• Gas chromatography-Mass spectroscopy (GC-MS). 
• Liquid chromatography-Mass spectroscopy (LC-MS). 
SPECTROPHOTOMETRIC METHODS: 
Spectrophotometry is generally preferred by industries as the cost of the equipment is less 
and the maintenance problems are minimal. The method of analysis based on measuring the 
absorption of a monochromatic light by colourless compounds in the near ultraviolet path of 
spectrum (200-380nm).3The photometric methods of analysis are based on the Bouger-
Lambert Beer,s Law, which establishes that the absorbance of a solution is directly 
proportional to the concentration of the analyte .The fundamental principle of operation of 
spectrophotometer covering UV region consists in that light of definite interval of wavelength 
passes through a cell with solvent and falls on to photoelectric cell that transforms the radiant 
energy into electrical energy measured by galvanometer. 
The important applications are 
• Identification of much type of organic, inorganic molecules and ions. 
• Quantitative determination of many biological, organic and inorganic species. 
• Quantitative determination of mixtures of analytes. 
• Monitoring and identification of chromatographic of effluents. 
• Determination of equilibrium constants. 
• Determination of stoichiometry and chemical reaction. 
• Monitoring of environmental and industrial process. 
• Monitoring of reaction rates. 
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INTRODUCTION TO ULTRA-VIOLET SPECTROPHOTOMETRY 
Molecular absorption in the ultraviolet and visible region of the spectrum is dependent on the 
electronic structure of the molecule. Absorption of energy is quantized, resulting in the 
elevation of electrons from orbital in the ground state to higher energy orbital in the excited 
state.4 
The wavelength range of UV radiation starts at the blue end of the visible light and ends at 
2000A0.The ultraviolet region is subdivided into two spectral regions. 
1. The region between 2000-4000A0 is known as near ultraviolet region. 
2. The region below 2000A0 is called the far or vacuum ultraviolet region. 
Wavelengths in the ultraviolet region are usually expressed in nanometres (1nm=10-7cm) or  
angstroms (A0) ,(1A0=10-8cm) occasionally absorption is reported in wave numbers (v=cm-1). 
White light is made up of a large number of individual waves of varying wavelength. This is 
shown by passing a beam of light through a prism. When a band of colour, is formed in 
which each colour corresponds to waves of particular wavelength. Complete spectrum of 
electromagnetic radiation extends from the ultra-short wave region of the cosmic rays at one 
end to that of radio wave at the other. 
Wavelength: 
Distance between any two consecutive parts of the wave for example from the crest of one 
wave to that of the next. Its symbol is λ (lambda). 
Wave number: 
This is defined as the reciprocal of the wavelength expressed in cm-1 i.e. the number of waves 
per unit cm. Its units are cm-1. 
Frequency: 
This is number of waves passing a point in one second i.e. the number of cycles per second. 
Its symbol is  letter nu. 
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Atomic Absorption: 
The excitation of electrons in atomic orbital to higher energy states may be induced by 
electromagnetic radiation of the energy. If the radiation exactly matches to difference 
between the  upper and lower energy states. 
Atomic absorption Spectrophotometry is the technique for quantitative determination of 
elements which is based on the measurement of absorption of monochromatic light by ground 
state atoms. 
Molecular Absorption5: 
The total energy of a molecule is the sum of electronic, vibrational and rotational energies. 
The relative energies required to induce electronic, vibrational, rotational transitions between 
the quantized energy levels are approximately 10,000:100:1. 
At room temperature the energy of most molecules in the ground electronic (EE) and 
vibration (Evib)  states .As a result certain electrons within molecules undergo a transition to 
an excite energy state and this is normally accompanied by an increase in the vibrational and 
rotational energies of the molecule. 
                ∆E= (EE +Evib + Erot) upper-(EE + Evib+ Erot) lower 
The technique of ultraviolet–visible spectrophotometry is one of the most frequently 
employed in pharmaceutical analysis. It involves the measurement of the amount of 
ultraviolet (190-380) or visible (380-800nm) radiation absorbed by a substance in solution. 
Instruments which measure the ratio or a function of the ratio of the intensity of two beams of 
light in the ultraviolet visible region are called UV-visible spectrophotometers. 
When a beam of light is passed through a transparent cell containing  a  solution of an 
absorbing substance, reduction of the intensity of the light may occur. This is due to: 
a. Reflection at the inner and outer surfaces of the cell. 
b. Scatter by particles in the solution. 
c. Absorption of light by molecules in the solution. 
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The reflections at the cell surface can be compensated by a reference cell containing the 
solvent only, and scatter may be eliminated by filtration of the solution. The intensity of light 
absorbed is then given by 
                                                       I absorbed=I0-IT 
Where I0 is the original intensity incident on the cell and IT is the reduced intensity 
transmitted from the cell. The transmittance (T) is the ratio IT/I0 and the % transmittance 
(%T) is given by 
%ܶ ൌ 100ܫ்/ܫ଴ 
The Beer-Lambert relationship is a relationship of transmittance and absorbance with the 
concentration of the substance in a solution. 
                                          A =abc = logI0I = logI/T 
Where ‘a’ is called absorptivity, which is constant. The name and “a” value of a depend on 
the units of concentration. Where “c” is in moles/litre, the constant is called molar 
absorptivity and has the symbol E. The equation therefore takes the form. 
                                             A = bc 
The molar absorptivity at a specified wavelength of a substance in solution is the absorbance 
at the wavelength of a1mol/L solution in a 1 cm cell. The unit of therefore are 1 mol-1cm-1. 
Another one is the specific absorbance which is the absorbance of a 1g/100ml (1%w/v) 
solution in a 1 cm cell. 
                                      A       =     A1%1cmbc 
Where c is concentration in g/100ml and b is the band length in cm. The units of A1%1cm 
dlg- 1cm-1. 
A simple easily derived equation allows interconversation of    and A1%1cm values. 
                                                =A1%1cm×molecular weight/10 
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QUANTITATIVE SPECTROPHOTOMETRIC ASSAY 6 
Assay of single component samples 
a)  Single standard or Direct Comparison Method: 
In this method the absorbance of a standard solution of known concentration and a sample 
solution is measured .The concentration of unknown can be calculated using the formula. 
                                          C2    =C1xA2/A1 
                   A1,A2  =    Absorbance of standard and sample 
                  C1 and C2  =  Concentration of standard and sample 
b)  Calibration curve method or multiple standard method: 
A calibration curve is plotted using –concentration vs. absorbance value of five or more 
standard solution. A straight line is drawn either through maximum number of points or in 
such a way that there is equal magnitude of positive and negative errors that is line of best fit. 
From the absorbance of the sample solution and using the calibration curve, the concentration 
of the drug, amount and percentage purity can be calculated. 
Assay of substances in multi compound sample: 
The basis of all the spectrophotometric techniques for multi compound samples is the 
property that all samples show the property of ---- 
1.   Absorbance which is the sum of absorbance of the individual components. 
2.   The measured absorbance is the difference between the total absorbance of the solution in 
the sample cell and that of the solution in the reference (blank) cell. 
Simultaneous equation method: 
If a sample contains two drugs (X and Y) each of which absorbs at the λ max of the other, it 
may be possible to determine both drugs by the simultaneous equation method (Vierodt’s 
method). 
When both substances contribute to the absorption at each wavelength, the calculation is as 
follows: 
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Let component a have E11 values of a1 at λ 1 and a2 at λ2 
Let component b have E11 values of b1at λ1 and b2 at λ2 
The extinction of a solution of the mixture is determined at λ1 and λ2 and the E11 values are 
calculated-s1 and s2 at λ1 and λ2 respectively. 
Then 
                                                         100 S1   =    a1x   +   b1y 
And         100 S2   =   a2x   +   b2y 
Where 
                           X   = concentration   (as %w/w) of component a 
                            Y =   concentration (as %w/w) of component b 
Solving the simultaneous equation for x and y. 
                                                        X   = 100        b1S2 - b2S2 
                                                                                b1a2 – b2a1 
 
                                                            Y =   100      a1S2 - a2S1 
                                                                                a1b2 – a2b1 
It should be confirmed that the extinctions of the two substances are additive and the 
wavelengths selected. 
Using the above equations, concentration of individual components in a mixture can be 
determined. 
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MEANING OF CHROMATOGRAPHY AND ITS TYPE 
Chromatography is a method used for separating organic and inorganic compounds so that 
they can be analysed and studied. Chromatography is a great physical method for observing 
mixtures and solvents. The word chromatography means colour separation where chroma 
means colour and graphy means separation. Chromatography is based on different migration. 
Solutes with a greater affinity for the mobile phase will spend more time in this phase than 
solutes that prefer the stationary phase. As the solutes move through the stationary phase the 
different components are going to be absorbed and are going to stop moving with mobile 
phase .Thus they are separated. This is called as chromatographic development. 
THE DIFFERENT TYPE OF CHROMATOGRAPHY  7 
1. Adsorption chromatography: 
Adsorption chromatography is probably one of the oldest types of chromatography around. It 
utilises a mobile liquid or gaseous phase that is absorbed on to the surface of a stationary 
solid phase. The equilibrium between the mobile and stationary phase accounts for the 
separation of different solutes. 
2. Partition chromatography: 
This form of chromatography is based on thin film formed on the surface of a solid support 
by a liquid stationary phase .Solutes equilibrates between the mobile phase and the stationary 
liquid. 
3. Ion exchange chromatography: 
In this type of chromatography, the use of a resin (the stationary solid phase) is used to 
covalently attach anions or cations to it. Solute ions of the opposite charge in the mobile 
liquid phase are attracted to the resin by electrostatic forces. 
4. Molecular exclusion chromatography: 
Also known as gel permeation or gel filtration, this type of chromatography lacks an 
attractive interaction between stationary phase and solute. The liquid or gaseous phase passes 
through a porous gel, which separates the molecule according to its size. The pores are 
normally small and exclude the larger solute molecule, but allow smaller molecule to enter 
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the gel, causing them to flow through a larger volume. This causes the larger molecules to 
pass through the column at a faster rate than the smaller ones. 
5. Affinity chromatography: 
This is the most selective type of chromatography employed. It utilises the specific 
interaction between one kind of solute molecule and a second molecule that is immobilised 
on a stationary phase. For example the immobilised molecule may be an antibody to some 
specific protein. When solute containing a mixture of protein is passed by this molecule, only 
the specific protein is reacted to this antibody, it to the binding stationary phase. This protein 
is later extracted by changing the ionic strength or PH. 
High performance liquid chromatography: 
HPLC is able to separate macromolecules and ionic species labile natural products, polymeric 
materials, and a wide variety of other high –molecular weight poly functional group. HPLC is 
the fastest growing analytical technique for the analysis of the drugs. It’s simplicity, high 
specificity, and wide range of sensitivity makes it ideal for the analysis of many drugs in both 
dosage forms and biological fluids .In this ,the separation is about 100 times faster than the 
conventional liquid chromatography due to packing of particles in the range of 3-
10µm.Modern LC uses very small particles for packing. The small particle size results in 
more rapid approach to the distribution equilibrium and consequently smaller plate height, so 
that a given length of column includes large number of plates which makes the column 
efficient and the peak narrow. But close packing of these small particles reduces the flow rate 
of the mobile phase through the packed bed (the packing said to develop high back pressure) 
and in order to achieve a reasonable flow rate it is necessary to apply pressure to the mobile 
phase. So the designation,  put forth as high pressure liquid chromatography. Thus HPLC is 
having advantages of improved resolution, faster separation, improved accuracy, precision 
and sensitivity. 
According to the phases involved, HPLC can be classified into several types which is as 
follows 
1.      Normal phase chromatography (NPC) 
2.      Reverse –Phase chromatography (RPC) 
3.     Liquid –solid chromatography or adsorption HPLC 
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4.      Liquid-liquid chromatography or partition HPLC 
5.      Ion exchange chromatography or ion exchange HPLC 
6.      Size exclusion or gel permeation or steric exclusion HPLC  
7.       Ion pair HPLC  
8.       Affinity HPLC 
Normal Phase Chromatography (NPC): 
In normal phase chromatograph, the stationary phase is more polar than the mobile phase, 
and the mobile phase is a mixture of organic solvents without added water (eg.Isopropane 
with hexane) and the column packing is either an inorganic adsorbent( silica) or a polar 
bonded phase (cyano, diol,amino ) on a silica support. Sample retention in normal phase 
chromatography increases as the polarity of the mobile phase decreases. They are eluted in 
the order of increasing polarities. 
Reverse phase chromatography: 
In reverse phase chromatography, the stationary phase is less polar than the mobile phase and 
the mobile phase is a mixture of organic and aqueous phase. Reverse phase chromatography 
is typically more convenient and rugged than the other forms of liquid chromatography and is 
more likely to result in a satisfactory final separation. High Performance RPC columns are 
efficient stable and reproducible. In this the solutes are eluted in the order of their decreasing 
polarities. These are prepared by treating the surface silanol group of site with an organic 
chloro silane reagent. 
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Basic principle of HPLC  8 
 
High performance liquid chromatography (HPLC) is a separation technique utilizing 
differences in distribution of compounds to two phases, called stationary phase and mobile 
phase. The stationary phase designates a thin layer created on the surface of fine particles and 
the mobile phase designates the liquid flowing over the particles. Under a certain dynamic 
condition, each component in a sample has difference distribution equilibrium depending on 
the solubility in the phase and or molecule size. As a result, components move at different 
speed over the stationary phase and thereby separated from each other. The column is a 
stainless steel or resin tube, which is packed with spherical solid particles. Mobile phase is 
constantly fed into the column inlet at a constant rate by a liquid pump. A sample is injected 
from the sample injector, located near the column inlet. The injected sample enters the 
column with mobile phase and the components in the sample migrates through it, passing 
between the stationary and mobile phase. Compound move in the column only when it is in 
mobile phase. Compounds that tend to be distributed in the stationary phase migrate slower. 
In this way,each component is separated on the column and sequentially elute from the outlet. 
Each component eluting from the column is detected by a detector to the outlet of the column 
.When the separation process is monitored by the recorders starting at the time of sample is 
injected, a graph is obtained. This graph is called chromatogram. The time required for a 
compound to elute (called retention time) and the relationship between compound 
concentration (amount) and peak area depend on the characteristic of the compound. 
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Retention is therefore used as an index for qualitative determination and peak surface area as 
index for quantitative determination. There are two modes of elution process 
a)     Isocratic elution 
b)     Gradient elution 
Selectivity of HPLC –method development 
Most of the drug can be analyzed by HPLC because of several advantages and ease of 
automation and eliminates tedious extraction and isolation procedures. Some advantages are:- 
 
1.   Speed (analysis can be accomplished in 20 minutes or less). 
2.    Greater sensitivity (various detectors can be employed). 
3.     Improved resolution. 
4.     Reliable columns (wide variety of stationary phase). 
5.     Ideal for substance of low volatility. 
6.     Easy sample recovery, handling, and maintenance. 
7.     Easy programming of the numerous functions in each module. 
8.    Time programmable operation sequence, such as initiating operation of detector lamp 
and  isocratic pump to obtain stable base line and equilibrated column before the work day 
begins. 
9.    Excellent reproducibility of retention time. 
10.  An injection volume variable from 0.1 to100 micro litres without any hardware 
modification. 
11.     The flexibility of data analysis. 
12.      Suitable to avoid any interference from impurity. 
13.       Suitable for preparative liquid chromatography on a much large scale. 
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Initial conditions for the development  9 
If HPLC is chosen for the separation, the next step is to classify the sample as regular or 
special. We define regular samples as typical mixtures of small molecules (<2000 Da), that 
can be separated using more or less standardized starting conditions. Regular samples can be 
further classified as neutral or ionic. If the sample is neutral, buffers or additives are generally 
not required in the mobile phase. Ionic samples require the addition of a buffer to the mobile 
phase. For basic or cationic sample , “less acidic”  reversed phase columns are recommended 
and amine addition for the mobile phase is beneficial. 
A good method of development strategies should require as many experimental runs as 
necessary to achieve the desired final result. 
Nature of the sample: 
Before the development, we need to review what is known about the sample. The goals of the 
separation should also be defined at this point. The  chemical composition of the sample can 
provide valuable clues for the best choice of initial conditions and HPLC separation. 
Important information concerning sample composition and properties. 
1.  Number of compounds present 
2.  Chemical structures (functionality) of compounds 
3.  Molecular weights of compounds 
4.  pka values of compounds 
5.  UV spectra of compounds 
6.  Concentration range of compounds in samples of interest 
7.  Samples solubility 
Sample Pretreatment and Detection: 
1. Solutions ready for injection 
2. Solutions that requires dilution, buffering, addition of an internal standard or other 
volumetric manipulation. 
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3. Solid that must first be dissolved or extracted 
4. Samples that requires, sample pretreatment to remove interference and/or protect the 
column or equipment from damage. 
Best results are often obtained when the composition of the simple solvent is close to that of 
the mobile phase, since this minimizes baseline upset and other problems. Some samples 
require a partial separation ( pretreatment ) prior to HPLC, because of the need to resolve 
interferences, concentrate sample analytes, or eliminate “column killers”. Before the first 
sample is injected during HPLC method development, we must be reasonably sure that the 
detector selected will sense all sample components of interest. For this various types of 
detectors are used. 
The aim of sample preparation is that the sample aliquot should be (1) relatively free of 
interferences,(2) will not damage the column and (3) is compatible with intended HPLC 
method, that is sample solvent will dissolve in the mobile phase without affecting sample 
retention or resolution. A sample pretreatment procedure should provide quantitative 
recovery of analytes, involve a minimum number of steps and be easily automated. 
Quantitative recovery of each analyte enhances sensitivity and assay precision, although this 
does not mean that all the analyte present in the original sample must be included in the final 
injected sample. If recovery is less than 100% the sample pretreatment must be reproducible. 
Derivatization: 
Derivatization involves a chemical reaction between analyte and a reagent to change the 
chemical and physical properties of an analyte. 
The four main uses of derivatization in HPLC are to 
1. Improve detectability 
2. Change the molecular structure or polarity of analyte for better chromatography 
3. Change the matrix for better separations 
4. Stabilize a sensitive analyte 
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Ideally, a derivatization reaction should be rapid, quantitative and produce minimal by 
products. Excess reagent should not interfere with the analysis or should be removed easily 
from the matrix. 
HPLC INSTRUMENTATION  10,11 
The general instrumentation for HPLC incorporates the following components 
• There is a solvent reservoir for the mobile phase 
• The mobile phase must be delivered to the column by some type of pump. The 
pumping system must be pulse-free or else have pulse damper to avoid generating 
baseline instability in the detector. 
• Sampling valves are used to inject the sample in the flowing mobile phase just at the 
head of the separation column. Samples should be dissolved in a portion of the mobile 
phase to eliminate an unnecessary peak. 
• A head of the separation column there may be a guard column or an in-line filter to 
prevent contamination of the main column by small particulate. 
• To measure column inlet pressure a pressure gauge is inserted in front of the 
separation column. 
• The separation column contains the packing needed to accomplish the desired HPLC 
separation. These may be silica’s for adsorption chromatography, bonded phase for 
liquid-liquid chromatography, ion exchange functional groups bonded to the 
stationary support for ion exchange chromatography, gels of specific porosity for 
exclusion chromatography, or some other unique packing for a particular separation 
method 
• A detector with some type of data handling device completes the basic 
instrumentation. 
Detectors: 
The sensitivity of universal detector for HPLC has not been devised yet. Thus it is 
necessary to select a detector on the basis of the problem. 
Buffers in Reversed-Phase Liquid Chromatography: 
Selection of a buffered aqueous mobile phase for reversed-phase liquid chromatography 
(RPC) may seen intimidating, but with an understanding of the fundamental effect of pH 
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on retention of ionic analytes and checking some properties of the buffer options, a 
logical and reasonable choice can be derived. This selection may need to be revised by 
consideration of certain factors, such solubility or limitations of compatibility with the 
means of detection. Practical aspects of buffer preparation should also be observed for 
reproducible and trouble free operations. 
The pH of the mobile phase will dramatically affect the retention of ionic analytes within 
1.5 pH units if their PKa Thus, it can be understood why control of mobile phase pH has 
great utility in method development and is critical for functional groups reproducible 
separations of ionic analytes. Obviously, if the analyte is not ionic mobile phase pH wont 
directly affect its retention. 
Chromatographic parameters:  
Resolution: 
Chromatographers measure the quality of separation by resolution Rs of adjacent bands 
 
 
 
Where tw1 and tw2 are obtained from the intersection of the tangents with the baseline. For 
a symmetrical Gaussian peak the tangents are drawn at 0.6times the peak height. 
Capacity factor:  
It is the measure of how well the sample molecule is retained by the column during an 
isocratic separation. It is affected by solvent composition, separation aging and 
temperature of separation. 
                                                            K1    =   tr  -t0/t0 
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tr      =   Band separation time 
t0     =  column dead volume 
Column efficiency: 
It is called as number of theoretical plates. It measures the band spreading of a peak. 
When band spread is smaller, the number of theoretical plate is higher. It indicates a good 
column and system performance. 
Column performance can be defined in terms of values of N 
 
Where:  
N = Number of theoretical plates 
Ve     =   elution volume, retention time or retention distance (mL, sec, or cm) 
h  =  peak height  
wb  =  width of the peak at the base line (ml, sec, or cm) 
Peak Asymmetry and Peak tailing: 
Peak Asymmetry: 
               Peak with poor symmetry can result in 
• Inaccurate plate number and resolution measurement 
• Imprecise quantitation 
• Degraded  resolution  and undetected minor bands in the peak tail 
• Poor retention reproducibility 
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Where:  
As = peak asymmetry factor 
b = distance from the point at peak midpoint to the tailing edge  
(measured at 10% of peak height) 
a = distance from the leading edge of  peak to the midpoint  
(measured at 10% of peak height) 
Peak tailing: 
 
 
 
Where:  
T = tailing factor (measured at 5% of peak height) 
b = distance the point from at peak midpoint to the tailing edge  
a = distance from the leading edge of the peak to the midpoint 
Increased peak asymmetry value, AS >  1.5 the sign that the column should be changed 
Selectivity: 
It measures relative retention of two components. Selectivity is the function of 
chromatographic surface ( column), melting point and temperature. 
                                α=    K2/K1  =    V2-V0/V1-V0 
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HPTLC METHOD DEVELOPMENT   12, 13 
HPTLC- High Performance Thin Layer Chromatography is a sophisticated and automated 
form of TLC. 
Main difference of HPTLC and TLC- Particle and pore size of sorbents. The other 
differences are: 
Parameters HPTLC TLC 
Layer of sorbent 100µm 250µm 
Efficiency High due to smaller particle 
size generated 
Less 
Separations 3-5cm 10-15cm 
Analysis time Shorter migration distance 
and the analysis time is 
greatly reduced 
Slower 
Solid support Wide choice of stationary 
phases like silica gel for 
normal phase and C8, C18 
for reversed phase modes 
Silica gel, Alumina and 
Kiesulghur 
Development chamber New type that require less 
amount of mobile phase 
More amount 
Sample spotting Auto-sampler Manual spotting 
Scanning Use Camag TLC scanner  of 
UV/Visible/Fluorescence 
scanner scans the entire 
chromatogram qualitatively 
and quantitatively and the 
scanner is an advanced type 
of densitometer 
Not possible 
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Features of HPTLC   14-16 
1. Simultaneous processing of sample and standard-better analytical precision and accuracy 
less need for internal standard. 
2.   Several analysts work simultaneously 
3.   Lower analysis time and less cost per analysis 
4.   Low maintenance cost 
5.   Simple sample preparation- handle samples 
6  .No prior treatment for solvents like filtration and degassing 
7.   Low mobile phase consumption per sample 
8.  No interference from previous analysis – fresh stationary and mobile phases for each 
analysis – no contamination 
9.   Visual detection possible open system 
10.  Non UV absorbing compounds detected by post- chromatographic derivatisation 
 
 
 
 
 
 
 
 
 
  Sample and standard preparation 
    Application of sample and standard 
    Chromatographic development
Detection of spots
      Scanning and documentation of chromate plate 
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Selection of chromatographic layer: 
• Precoated plates – different support materials –different sorbents available 
• 80% of analysis –silica gel GF . Basic substances, alkaloids and steroids-
aluminium oxide 
• Amino acids, dipeptides, sugars and alkaloids-cellulose 
• Non-polar substances, fatty acids, carotenoids, cholesterol-RP2,RP8 and 
Preservatives, barbiturates, analgesic and phenothiazines- Hybrid plates-RPWF254s 
Activation of pre-coated plates: 
• Freshly open box of plates do not require activation 
• Plates exposed to high humidity or kept on hand for long time to be activated 
• By placing in an oven at 110-1200c for 30’ prior to spotting 
• Aluminium sheets should be in between two glass plates and placing in an oven 
at110-1200c for 15 minutes. 
Application of sample and standard: 
• Usual concentration range is 0.1µg/µl 
• Above this causes poor separation 
• Linomat IV(automatic applicator)-nitrogen gas sprays sample and standard from 
syringe on TLC plates as bands 
• Band wise application-better separation- high response to densitometer 
• Selection of mobile phase 
• Trial and error 
• One’ own experience and literature 
• Normal phase 
• Stationary phase is polar 
• Mobile phase is non polar 
• Non –polar compounds eluted first because of lower affinity with stationary phase 
• Polar compounds retained because of higher affinity with the stationary phase 
• Reversed phase 
• Stationary phase is non polar 
• Mobile phase is polar 
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• Polar compounds eluted first because of lower affinity with stationary phase 
• Non-polar compounds retained because of higher affinity with the stationary phase 
• 3-4 component mobile phase should be avoided 
• Multi component mobile phase once used not recommended for further use and 
solvent composition is expressed by volumes (v/v) and sum of volumes is usually100 
• Twin trough chambers are used only 10-15 ml of mobile phase is required 
• Components of mobile phase should be mixed introduced into the twin- trough 
chamber 
Pre conditioning (Chamber saturation ): 
• Unsaturated chamber causes high Rf values 
• Saturated chamber by lining with filter paper for 30 minutes prior to development –
uniform distribution of solvent vapours-less solvent for the sample to travel-lower Rf 
values. 
Chromatographic development and drying: 
After development, remove the plate and mobile is removed from the plate- to avoid 
contamination of lab atmosphere. Dry vacuum desiccator-avoid hair-drier-essential oil 
components may evaporate 
Detection and visualization: 
• Detection under UV light is first choice- non destructive 
• Spots of fluorescent compounds can be seen at 254 nm (short wavelength) or at 
366nm (long wavelength) 
• Spots of non-fluorescent compounds can be seen-fluorescent stationary is used-silica 
gel GF 
• Non UV absorbing compounds ilike ethambutol, dicyclomine etc –dipping the plates 
in 0.1% iodine solution 
• When individual compound does not respond to UV –derivetisation required for 
detection 
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Quantification: 
• Sample and standard should be chromatographed on same plate- after development 
chromatogram is scanned 
• Camag TLC scanner III scan the chromatogram in reflectance or in transmittance 
mode by absorbance or by fluorescent mode-scanning speed is selectable upto 
100mm/s-spectra recording is fast-36 tracks with upto 100 peak windows can be 
evaluated 
• Calibration of single and multiple levels with linear or non linear regressions are 
possible. When target values are to be verified such as stability testing and dissolution 
profile single level calibration is suitable 
• Statistics such as RSD or CI report automatically 
• Concentration of analyte in the sample is calculated by considering the sample 
initially taken and dilution factors 
Documentation: 
• E-Merck introduced plates with imprinted identification code- supplier name. Item 
number, batch number and individual plate number-Avoid manipulation of data at 
any stage –coding automatically get recorded during photo documentation 
METHOD VALIDATION AND ITS TYPE17 
Validation is a documented program that provides a high degree of assurance that a facility or 
operation will consistenly produce product meeting a predetermined specifications. 
Why Validate? 
Economical reasons: 
• Rapid and reliable up 
• Robust process 
• Reduction in rejections/rework/recalls 
• Reduce testing 
• Rapid introduction 
• To increase the productivity 
• To target and reduce the number of controls 
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• To reduce product cost 
Method Validation18-20 
According to method, validation can be defined as “Establishing documented evidence which 
provides a high degree of assurance that a specific activity will consistently produce a desired 
result or product meeting its pre determined specification and quality characteristics. 
Method validation is an integral part of the method development; it is the process of 
demonstrating that analytical procedures are suitable for their intended use and that they 
support the identity, quality, purity and potency of the drug substances and drug products. 
Simply, method validation is the process of proving that an analytical method is acceptable 
for its intended purpose. 
Method validation, however, is generally a one –time process performed after the method has 
been developed to demonstrate that the method is scientifically sound and that it serves the 
intended analytical purpose. 
All the variables of the method should be considered, including sampling procedure, sample 
preparation, chromatographic separation, and detection and data evaluation. For 
chromatographic methods used in analytical applications there is more consistency in 
validation practice with key analytical parameters including 
Selectivity: 
Ability of the developed analytical method to detect analyte quantitatively in the presence of 
other components, which are expected to be present in the sample matrix or other related 
substances. Results are expressed as resolution. If the expected impurities or related 
substances are available, they should be analyzed along with the analyte or sample to check 
the system suitability, retention factor, tailing factor and resolution etc. 
Linearity: 
It is the ability of the method to elicit test results that are directly proportional to analyte 
concentration within a given range. It is generally reported as variance of slope of regression 
line. It is determined by series of three to six injections of five or more standards. 
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Range: 
It is interval between the upper and lower levels of analyte, which is studied. The range is 
normally expressed in the same units as the test results obtained by the analytical method. 
The ICH guidelines specify a minimum of five concentration levels. 
Precision: 
It is a measure of degree or repeatability of an analytical method under normal operation and 
it is normally expressed as % of relative standard deviation (% RSD). 
                                               % RSD  =   100S/X 
Where, S=  Standard deviation, X = Mean 
It is determined at three levels. 
Repeatability: 
It is obtained when analysis is carried out in one laboratory by one operator using one piece 
of equipment over relatively short time span at least 5 or 6 determinations of three different 
matrices at 2 or 3 different concentrations. 
Intermediate Precision: 
It is determined by comparing the results of a method run within a single laboratory over a 
number of weeks. A method intermediate precision may reflect discrepancies in results 
obtained by different operators, from different instruments, with standards and reagents from 
different suppliers, with column of different batches. 
Reproducibility: 
It represents the precision obtained between laboratories. The objective to verify that the 
method will provide the same results in different laboratories. It is determined by analyzing  
aliquots from homogenous lots in different laboratories with different analysts with specified 
parameters of method. 
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Accuracy: 
It is the measure of how close the experimental value to the true value. Accuracy studies, for 
drug substance and drug product are recommended to be performed at 50%, 100%, and 150% 
levels of label claim. Three replicates of each concentration should be there and the mean is 
an estimate of accuracy. 
Limit of Detection (LOD): 
It is defined as the lowest concentration of an analyte in a sample that can be detected but  not 
quantified. LOD is expressed as a concentration at a specified signal to noise ratio. In 
chromatography detection limit is injected amount that result in a peak with a height atleast 
twice or thrice as high as baseline noise level. S/N 2/1 or 3/1. 
Limit of quantification (LOQ ): 
It is defined as lowest concentration of analyte in asample that can be determined with 
acceptable precision and accuracy under stated operational conditions of the method. LOQ is 
expressed as a concentration at aspecified signal to noise ratio. In chromatography detection 
limit is the injected amount that results in a peak with height ten times as high as base line 
noise level. 
                                                    S/N  =   10/1 
Specificity: 
Specificity is the ability to measure accurately and specifically the analyte of interest in the 
presence of other components that may be expected to be present in the sample matrix. It is a 
measure of a degree of interference from such things as other active ingredients, excipients, 
impurities, and degradation products, ensuring that a peak responses due to a single 
component only. i.e. that no co- elutions exist. Specificity is measured and documented in a 
separation by the resolution, plate count (efficiency), and tailing factor. 
Ruggedness: 
Ruggedness is the degree of reproducibility of the results obtained under a variety of 
conditions, expressed as % RSD. These conditions include different laboratories,analysts, 
instruments, reagents, days, etc. In guideline on definitions and terminology, the ICH did not 
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address ruggedness specifically. However, as ICH chose instead to cover the topic of 
ruggedness as part of precision, as discussed previously. 
Robustness: 
Robustness is the capacity of a method to remain unaffected by small deliberate variation in 
method parameters. The robustness of a method is evaluated by varying method parameters 
such as percent organic,pH, ionic strength, temperature etc;and determining the effect (if any) 
on the results of the method.As documented in the ICH guidelines, robustness should be 
considered early in the development of  a method. In addition, if the results of a method or 
other measurements are susceptible to variations in method parameters, these parameters 
should be adequately controlled and a precautionary statement included in the method 
documentation. 
System suitability testing: 
System suitability tests are an integral part of chromatographic methods. These tests are used 
to verify that the resolution and reproducibility of the system are adequate for the analysis to 
be performed. System suitability tests are based on the concept that the equipment, 
electronics, analytical operations, and samples constitute an integral system that can be 
evaluated as a whole. System suitability is the checking of a system to ensure system 
performance before or during the analysis of unknowns. Parameters such as plate count, 
tailing factors, resolution and reproducibility (%RSD retention time and area for six 
repetitions) are determined and compared against the specifications set for the method. 
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  LITERATURE REVIEW 
Suddhasattya Dey et al21 develop HPLC method for the estimation of carvedilol in bulk and 
pharmaceutical dosage form. The specification of the chromatographic system, column 
4.6mm×25cm, 5 micron, with mobile phase containing phosphate buffer: acetonitrile, PH 2, 
wavelength 240nm, flow rate 1ml/min and the oven temperature 55⁰C. Retention time was 
6.63.  A linear response was observed between the concentration rangeof 806-1202µg/ml 
with a regression co-efficient of 0.99.  
Navaneet Verma et al22 reported a procedure for simultaneous estimation of carvedilol in its 
dosage form. The UV absorbance maxima of the drug at 285 nm. The drug obeyed Beer’s 
law in the concentration range of 4-36µg/ml with molar absorptivity of 12.6 ×103 l/mol. Cm 
in methanol. 
Satish A Patel et al23 developed UV spectrophotometric method for the determination of 
carvedilol in tablet formulation. Simple UV spectrophotometric method is based on 
determination of carvedilol in 0.1 N HCL at 241.2 nm. Linearity was obtained in the 
concentration range of 1- 12µg/ml.  
M. Imran et al24 developed a new and rapid stability indicating ultraviolet spectroscopic 
methods for the estimation of ezetimibe and carvedilol in pure form and in their respective 
formulations. The linearity range for ezetimibe and carvedilol obtained as 2-50µg/ml and 2-
20µg/ml respectively. 
Ivan Savic et al25 developed a method to select an appropriate packaging and analysis of its 
influence on stability of tablets containing carvedilol. After radiation the content was 
estimated using a validated hplc – method. Retention time was 4.5 detected at 240 nm. 
T.E.G.K Murthy et al26 reported a development of scriminatory method for dissolution  of 
carvedilol marketed formulations .In the study four dissolution media with different agitation 
speeds were employed. An agitation speed of 100 rpm showed more drug release profile than 
50 and 75 rpm. 
Ramesh Gannu et al27 developed a HPLC analytical method for carvedilol in human serum. 
The method employs a liquid-liquid extraction for isolation and sample concentration 
followed by reversed phase liquid chromatography analysis using ultraviolet detection at 
238nm. Serum samples containing the carvedilol and internal standard and amitriptyline were 
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eluted through a C8 kromasil KR 100 5C8 column . Retention time of carvedilol was 6.10 
min.    
L. J Patel et al28 developed reverse phase high performance liquid chromatography and high 
performance thin layer chromatography for estimation of carvedilol in bulk drug and 
pharmaceutical formulations. For HPLC method Lichrospher 100-c18(200×4.6mm), 5µ 
column, isocratic mode, with mobile phase containing 50M potassium di hydrogen phosphate 
buffer: actonitrile : methanol ( 60:50:10) was used.  The retention time was 4.56 .The 
linearity lies over 1-35µg/ml for HPLC. For HPTLC a CAMAG HPTLC system comprising 
of Linomat v automatic sample applicator , Hamilton syringe, Camag TLC scanner-3Camag 
Win CAT software with stationary phase precoated silica gel 60F254  and mobile phase 
consisting of ethyl acetate: toluene: methanol.  The detection of spot carried out at 242 nm. 
The Rf  value was 0.65. The linearity lies over 50 – 300 ng/spot for HPTLC. 
CH. Ajay. Babu29 developed a high performance liquid chromatography method for the 
determination of the carvedilol in human plasma. The method utilizes the liquid-liquid 
extraction with n-hexane ethyl acetate (3:1v/v). Samples were analysed by using phenomine 
Gemini C18 column with UV detection at 241nm. 
Laila Ei Sayed Abdel Fattah et al30 reported a spectrofluorimetric determination of 
carvedilol in dosage form and spiked human plasma through derivatization with 1-
dimethylamino-naphthalene-5-sulphonyl chloride. The fluorescence concentration plot was 
rectilinear over the range of 5.0-8.0ng/ml with a lower detection limit of 1.90ng/ml. 
Olga Galanopoulou et al31 reported HPLC analysis, isolation and identification of a new 
degradation product in carvedilol tablets. The separation was achieved with an X-terra C18 
column using acetonitrile - phosphate buffer pH2.5 as mobile phase. 
Sarath Chandiran et al32 reported a simultaneous quantification of carvedilol and its 
metabolite in human plasma by using High-throughput liquid chromatography - tandem mass 
spectrometric method .The method was linear over a concentration range of 0.1 to 250 ng/ml 
with a limit of quantification of 0.1ng/ml. 
R. K. Jat et al33 developed a sensitive and rapid extractive spectrophotometer method for the 
assay of carvedilol in bulk drug and tablets  The complex formed between carvedilol and 
bromophenol  blue in an acidic medium shows  maximum absorbance at 414nm. Linearity 
lies in the range of 5-20µg 
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.  
 F. Behn et al34 developed high performance liquid chromatography for the 
determination of the β receptor blocker .Carvedilol in small volumes of the plasma 
from paediatric patients. Analysis of the extracts was performed on a spherisorb C6 
column with a mobile phase of 65% acetonitrile and 35% potassium acetate buffer 
and fluorescence detection. Carvedilol and internal standard showed recoveries of 
87.0% and 97.7 % respectively. 
 J.Stojanovic et al35 developed a reverse phase high performance liquid 
chromatographic method for separation of carvedilol and its impurities from 
Karvileks tablets.  The best separation was achieved on a chromolit RP 8 e column. 
Use of acetonitrile : water (45 : 55) v/v adjusted to pH 2.5 with formic acid as mobile 
phase. UV detection was performed at 280nm. 
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DRUG PROFILE: 36, 37 
CARVEDIOL 
INTRODUCTION:  
Carvedilol tablets are indicated for the treatment of mild to severe chronic heart failure of 
ischemic  or cardio myopathic  origin .usually in addition to diuretics  ACE inhibitors and 
digitalis . They can be used alone or in combination with other antihypertensive  agents 
especially thiazide type diuretics should not be given to patients with severe hepatic 
impairment .It is a non selective  β-adrenergic blocking agent with  α-1 blocking activity 
.Carvedilol has much greater antioxidant activity than other commonly used β blockers 
.Tablet containing inactive ingredients as colloidal  silicon dioxide,  crospovidone, 
hypromellose, lactose monohydrate, magnesium stearate,  polyethylene glycol, polysorbate, 
povidone, and titanium dioxide. 
CHEMICAL STRUCTURE: 
 
CHEMICAL NAME : 
( ±)-[3-(9H-carbazol-4-yloxy)-2 hydroxy  propyl ] [2-(2-methoxy phenoxy) ethyl] amine. 
MOLECULAR FORMULA: 
C24H26N2O4 
MOLECULAR WEIGHT: 
406.5 
CHARECTERESTICS: 
White or off –white crystalline powder. 
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SOLUBILITY: 
Insoluble in water, sparingly soluble in 95% ethanol and isopropanol, slightly soluble in ethyl 
ether soluble in methanol, methylene chloride, freely soluble in dimethyl sulfoxide. 
MECHANISM OF ACTION: 
Carvedilol is a racemic mixture in which non-selective β- adreno receptor blocking activity is 
present in the S(-) enantiomers and α1 adrenergic blocking activity is present in both R(+) and 
S(-)  enantiomers at equal potency. Carvedilol has no intrinsic sympathomimetic activity. 
PHARMACOKINETICS: 
Bioavailability                       :  25-35 % 
Protein binding                      :   98% 
Metabolism                            :    Hepatic. 
Half life                                  :   7-10 hrs 
Excretion                                :    Renal 16%, Faecal 60%. 
THERAPEUTIC USES: 
• Antihypertensive agents. 
• Adrenergic β- antagonist. 
• Adrenergic α-antagonist. 
• Vasodilator agents. 
DOSAGE: 
Patients weighing < 85 kg (187 lb) - 25mg twice daily. 
Patient weighing > 85kg (187lb) -50mg twice daily. 
HOW TO USE: 
25 mg taken twice daily for two weeks .This dosage is same regardless of the age of weight  
of the patient. It should be swallowed as a whole tablet and should not crushed, and chewed 
.Carvedilol should be taken with food to slow the rate of absorption and reduce the incidence 
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of orthostatic effects .Patient should be observed in the office for one hour after initial dose is 
given. 
STORAGE: 
Store in a close, cool and light resistant container. 
BRAND NAMES: 
Cardivas, Coreg, Carvil, Karvileks. 
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          AIM AND OBJECTIVE 
 
The literature review reveals that several works have been carried out for the 
quantification of Carvedilol either individually or combination with other drugs and for the 
analysis of Carvedilol in biological fluids; including HPLC, Capillary electrophoresis, 
flourimetry, chemiluminescence, dissolution test. In these some methods are only for the 
estimation of drugs from biological fluids. 
The present study describes the development of a new rapid, simple, sensitive and 
reproducible RP-HPLC, HPTLC, UV Spectrophotometry method for the analysis of 
Carvedilol that offer certain advantages in its simplicity and sensitivity and applicable in 
routine analysis. It also describes the development of validation work as per ICH guidelines 
recommended by the Food and Drug Administration (FDA) of the United States.  
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          PLAN OF WORK 
 
Aimed to develop analytical method and validation for Carvedilol in a tablet dosage form. 
The plan of the proposed work includes the following steps. 
¾ The extensive survey of literature for Carvedilol regarding their characteristics and 
analytical methods. This forms the basis for the development of methods. 
¾ To undertake solubility studies for the analyte Carvedilol. 
¾ Selection of suitable solvent for quantitative extraction of analyte present in the 
formulations. 
¾ Selection of suitable stationary phase and mobile phase. 
¾ Selection of detection of wavelength. 
¾ Develop initial conditions for   HPLC, HPTLC,UV,  methods.   
¾ Optimization of the HPLC, HPTLC, UV,  methods. 
¾ Analytical method validation of the developed  HPLC, HPTLC,  and UV methods as 
per the ICH guidelines. 
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LIST OF INSTRUMENTS USED 
 
 
 
S.NO 
 
 
 
 
INSTRUMENT 
 
1 
 
 
SHIMADZU UV-1700 spectrophotometer 
 
2. 
 
SHIMADZU HPLC with UV detector 
 
3 
 
YMC pack pro C18 column (100 × 4.6mm, 5µ)  
 
4 
 
CAMAG HPTLC instrument 
 
5 
 
CAMAG TLC SCANNER 3 
 
6 
 
CAMAG LINNOMATE V AUTOMAIC SAMPLE  
APPLICATOR 
 
7 
 
Twin-trough chamber (10 × 10 cm) 
 
8 
 
Ultra Sonicator 
 
          9. 
 
Electronic balance (2mg-200gm) (Sartorius) 
 
10. 
 
pH Analyser 
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LIST OF CHEMICALS AND SOLVENTS 
 
 
S.NO 
 
 
 
CHEMICALS AND SOLVENTS 
 
MANUFACTURER 
 
1. 
 
 
Carvedilol working standard 
 
USP standards 
 
2. 
 
 
Acetonitrile (HPLC grade) 
 
Rankem 
 
3. 
 
 
Methanol (HPLC grade) 
 
Fischer scientific 
 
4. 
 
 
Potassium di hydrogen phosphate 
 
Merck  
 
5. 
 
 
Formic acid 
 
Merck  
 
6. 
 
 
Milli - Q/HPLC water 
 
Merck 
7 Toluene 
 
Merck 
8 Chloroform 
 
Merck 
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METHOD DEVELOPMENT FOR ASSAY OF CARVEDILOL TABLETS BY RP-
HPLC METHOD 
Selection of chromatographic method: 
            Proper selection of chromatographic method depends on the nature of the drug, 
molecular weight, and solubility. Since carvedilol is polar in nature, reverse phase 
chromatography has been used. 
Selection of mobile phase: 
             Various mobile phases were tried in different ratios for selection of mobile phase. 
The drug carvedilol was injected with different mobile phase at different ratios with different 
flow rates till a sharp peak without any interference peak containing spectrum was obtained. 
The different mobile phase were containing either one or the combinations of two or three of 
following solvents, acetonitrile, water, methanol, tetrahydrofuran. 
              Tried at different ratios no favourable results obtained. But the mobile phase 
containing potassium di hydrogen phosphate buffer : acetonitrile in the ratio 60:40 gave 
acceptable peak with retention time 2.97 min. 
Separation using acetonitrile and water 
        A mobile phase consisting acetonitrile and water at different ratios were tried to achieve 
the separation. But it was found that carvedilol peak was merging. 
Separation using methanol and water 
       Next trial was done by using mobile phase consisting methanol and water. Although 
different ratios were tried tailing of the peak occurred. 
Separation using tetrahydrofuran, acetonitrile and water 
        Tetrahydrofuran, acetonitrile, water composition as mobile phase were tried at different 
ratios peak shape was not found to be good. 
Separation using potassium di hydrogen phosphate buffer and acetonitrile. 
         Potassium di hydrogen phosphate buffer, acetonitrile composition as mobile phase were 
tried at different ratios. With this good symmetrical peaks were obtained. As our aim was to 
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get good symmetrical peaks, this mobile phase system was selected for further study. Fig 2(1) 
– 2(4). 
METHOD OPTIMIZATION 
INITIAL CHROMATOGRAPHIC CONDITION      
Column    - YMC pack pro  C18 (100×4.6mm)5µm 
Column temperature   - Ambient 
Flow rate   - 1ml/min 
Pump mode   - Isocratic 
Injection volume  - 10µl 
Run time   - 8 min 
PH                                                           -             3  
Mobile phase                           -         Phosphate Buffer :  ACN     
 Effect of ratio of mobile phase 
        After confirming the mobile phase, change in the ratio of mobile phase was done for the 
optimization of the peak. The ratio of 50: 50, 70: 30, 65: 35 were tried fig  2(5)- 2(7).  
In that case 60:40 v/v shows good retention time and resolution. The peak shown in figure 
2(11). 
Effect of flow rate 
     After confirming the ratio of mobile phase, flow rate of the mobile phase was changed, at 
0.8ml/min it shows increased retention time the flow rate of 1.2ml/min resulted in fronting of 
the peak. It shows fig 2(8)- 2(9). The flow rate of 1ml/min has given a good result. It is 
shown in fig. 2(11). 
Selection of column 
      The literature review showed the usage of C18 column for the determination of carvedilol. 
Mostly C18 column is used for analytical purpose and the column selected was YMC pack pro 
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C18 column. The column with different dimensions were tried but that showing shifting of 
retention time. It shows  fig 2(10). YMC pack pro C18 (100 × 4.6mm, 5µ) column shows 
good result. Fig 2(11). 
Selection of detector wavelength 
        The sensitivity of the HPLC method that uses UV detector depends upon the proper 
selection of wavelength. An ideal wavelength is one that gives maximum absorbance and 
good response for the drug to be detected. 
        UV detector as the most popular as they can be detect a broad range of compounds and 
have a fair degree of selectivity for some analytes and is useful for many  HPLC  
applications. For the detection, the analyte chemical structure should consist suitable 
chromophore such as aromatic ring and the solvent using should be UV grade or non UV 
absorbing solvents. 
           A UV spectrum of carvedilol was recorded. From this spectrum λmax at 242 nm was 
selected for the proposed study. 
   Figure1(1) acetonitrile: water. 
 
                                                Figure 1(2) methanol:water 
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Figure 1(6) buffer: acetonitrile at 70:30 ratio. 
 
 
                                 Figure 1(7) buffer :acetonitrile at 65:35 ratio. 
 
Figure 1(8) flow rate 0.8ml. 
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                                             Figure 1(9) shows flow rate 1.2 ml. 
 
 
Figure 1(10) shows column C18 (250× 4.6 mm) 
 
 
                                       Figure 1(11) shows good symmetric peak. 
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ASSAY BY HPLC 
Reagents                                                                 Grade 
Potassium di hydrogen phosphate                          AR 
Formic acid                                                             AR 
Acetonitrile                                                              HPLC 
Water                                                                        HPLC/MILLI-Q 
Chromatographic conditions 
Column                                                :  YMC pack pro c18(100×4.6mm,5µ) 
Column temperature     :             Ambient 
Flow rate                                             :  1.0ml/min 
Wavelength                                         :   242nm 
Injection volume                                 :  10µl 
Run time                                              :  8min 
PH                                                                                      :          3 
Mobile phase                                       :         Phosphate Buffer : ACN (60 : 40 ) 
SOLUTION  PREPARATIONS : 
PREPARATION OF BUFFER SOLUTION: 
Dissolve about 6.80g of potassium di hydrogen phosphate in1000 ml of HPLC/ Milli – Q 
water. 
Adjusts the pH to 3.0 ± 0.05 with formic acid. 
PREPARATION OF MOBILE PHASE: 
Prepare a mixture of buffer and acetonitrile   in the ratio of 60:40 Filter through 0.45µ 
Membrane filter and degas. 
                                                                                                                    Experimental Details 
 
Department Of Pharmaceutical Analysis, RVS College Of Pharmaceutical Sciences  Page 45 
 
PREPARATION OF STANDARD SOLUTION: 
Weigh accurately about 62.5mg of carvedilol reference /working standard in to a 100ml 
Volumetric flask,  add 30ml of methanol  sonicate to dissolve . Then make up to the volume 
With methanol . Pipette out 10ml of this solution into a100ml volumetric flask and 
dilute up to the mark with mobile phase. Filter through 0.45µ membrane filter. 
Prepare the standard solution in duplicate calculate the similarity factor for standard-I and 
Standard -II solutions by using the following formula. 
Area of standard solution-1                          ×          weight of STD ( in mg) solution-2 
Area of standard solution-2 (1st injection)                  weight of STD (in mg) solution-1 
Note: similarity factor for both the standard solutions should be between 0.98 to 1.02 
PREPARATION OF SAMPLE SOLUTIONS: 
For 25 mg tablets: 
Weigh and transfer 5 tablets into a100ml volumetric flask. Add 50ml of methanol and 
sonicate to dissolve then make up to the volume with methanol, pipette out 5ml of this 
solution into a 100ml volumetric flask and dilute up to the mark with mobile phase. Filter 
through 0.45µ membrane filter. 
PROCEDURE: 
Inject 10µl portions of blank, standard solution and sample solutions into the  
chromatograph and record the chromatograms. Record the peak responses for the major 
peaks. 
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                       TABLE 1.1  INJECTION  SEQUENCE: 
 
 
 
 
 
 
 
 
 
 
 
Name of Drug 
 
Retention  
Time 
Area Theoretical Plate Tailing Factor 
Carvedilol 
 
2.96 4121905 5350.4 1.40 
 
 
 
S.NO DESCRIPTION NUMBER OF 
INJECTION 
1 Blank  1 
2 Std solution-1                   1 
3 Std solution-II               1 
4 Std solution-II                4 
5 Sample solution 2 
6 Std solution                1 
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EVALUATION OF SYSTEM SUITABILITY: 
1. The relative standard deviation for five replicate injections should not be more than 2.0% 
2. Tailing factor for carvedilol peak should be not more than 2.5 
3. Theoretical plate for carvedilol peak should be not less than 1500 
VALIDATION PROGRAMME FOR ASSAY 
          TABLE 1.2 VALIDATION PARAMETERS 
S.NO PARAMETERS 
1 System suitability 
2 Specificity 
3 Accuracy/Recovery 
4 Linearity/and range 
5 Precision 
a) Repeatability 
b) Intermediate precision 
c) System precision 
d) Method precision 
6 Robustness 
7 Solution stability 
 
SYSTEM  SUITABILITY: 
Five replicate injections of the standard solutions were injected the percentage RSD for     the 
peak area and tailing factor for carvedilol were calculated. 
ACCEPTANCE CRITERIA: 
a) % RSD for standard injections should be not more than 2.0% 
b) Tailing factor for carvedilol peak should be not more than 2 
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                                  TABLE 1.3  SYSTEM SUITABILITY 
 
 
RESULT: 
a) % RSD for standard injections is 0.23% 
 
b) Tailing factor for carvedilol peak is 1.5 
SPECIFICITY: 
Blank,  placebo, standard, sample solution injected into HPLC system. There was no 
interference from the blank and placebo at the retention time of carvedilol peak. Peak purity 
reveals that carvedilol peak was homogeneous and there were no co-eluting peaks at the 
retention time of carvedilol peak. 
PLACEBO PREPARATION: 
Weighed and transferred 1.812 gm of placebo into 100ml volumetric flask, 50 ml of methanol 
added and  sonicated  to dissolve. Then made up to the volume with methanol. Pipette out 5 
ml of this solution into a 100 ml volumetric flask and diluted up to the mark with mobile 
phase. Filtered through 0.45µ membrane filter and injected into the chromatogram. 
 
 
No of injection 
 
 
Area 
 
Tailing factor 
1 4121144 1.514 
2 4111957 1.521 
3 4112953 1.520 
4 4135077 1.525 
5 4118577 1.516 
Average 4119942 1.519 
SD 9286.85  
%RSD 0.23  
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ACCEPTANCE CRITERIA: 
i) All individual peaks should be well separated. 
ii) The interference of carvedilol peak from the other peaks should be nil. 
iii) The purity of carvedilol peak should be NLT 0.99. 
RESULT: 
i. All individual peaks are well separated. 
ii. The interference of carvedilol peak from the other peaks is nil. 
iii. The purity of carvedilol  peak  is 0.99. 
ACCURACY/RECOVERY: 
Known amount of carvedilol spiked with placebo at about 80%,100%, and 120%of working 
concentration in triplicate and analysed as per testing procedure .The percentage recovery 
was calculated from the amount found and actual amount added. 
Figure1(12 ) accuracy at 80% 
 
                                            Figure1( 13 ) accuracy at 100%. 
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Figure 1 (14  ) shows accuracy at 120%. 
                                    
                                         TABLE 1.4  ACCURACY. 
LEVEL Amount 
found in µg 
Actual 
amount 
added in µg 
%recovery Mean %RSD 
Level-1 
80% 
19.80 
19.80 
19.78 
19.72 
19.72 
19.72 
100.4 
100.4 
100.3 
 
100.4 
 
0.07 
Level-2 
100% 
24.71 
24.69 
24.70 
24.64 
24.64 
24.64 
100.3 
100.2 
100.2 
 
100.2 
 
 
 
0.07 
 
Level-3 
120% 
29.76 
29.77 
29.81 
29.58 
29.58 
29.58 
 
100.6 
100.6 
100.8 
 
101.7 
 
 
0.12 
 
ACCEPTANCE CRITERIA: 
a) The % recovery should be in between 95% and 105%. 
b) The %RSD for all recovery values should be not more than 2%. 
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RESULT: 
a) The % recovery is in between 98.1% and102.7%. 
b) The % RSD for all recovery values is 0.64%. 
CONCLUSION: 
The analytical method   meets the acceptance criteria for accuracy study. Hence the method is 
accurate for the determination of assay of carvedilol tablets. 
LINEARITY AND RANGE 
   The linearity of an analytical procedure is its ability ( within a given range )to obtain test 
results which are directly proportional to the concentration ( amount ) of analyte in the 
sample. 
    The range of the analytical procedure is the interval between the upper and lower 
concentration ( amount ) of analyte in the sample ( including the concentrations). For which it 
has been demonstrated that the analytical procedure has a suitable level of precision, 
accuracy, and linearity. 
PROCEDURE: 
PREPARATION OF STANDARD STOCK SOLUTION: 
      Weigh accurately and transfer about 62.52 mg of carvedilol into a 100 ml volumetric 
flask. 50 ml methanol added and sonicated to dissolve, then make upto the volume with 
methanol. Pipette out 10 ml of this solution into a 100 ml volumetric flask and diluted upto 
the mark with mobile phase. Filtered through 0.45µ membrane filter. 
PREPARATION OF SAMPLE SOLUTION: 
    Transfer the accurately weighed samples 15.62,31.25, 46.88, 62.50, 78.13, 93.75 mg 
respectively into individual 100 ml flask . 50 ml methanol added and sonicated to dissolve, 
then make up to the volume with methanol. Pipette out 10 ml of this solution into a  100 ml 
volumetric flask and diluted up to the mark with mobile phase. Filtered through 0.45 µ 
membrane filter. 
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    Inject 10µl of blank solution and each linearity level standard solutions into the 
chromatographic system and measure the peak area . 
     The linearity of carvedilol was performed in the range of  15.62µg/ml to 93.75µg/ml (25%  
- 150 % of working concentration ). A graph was plotted with concentration in µg/ml on x 
axis and peak area on y axis. Slope, y intercept, correlation coefficient ( r value ), were 
determined. 
ACCEPTANCE CRITERIA: 
The correlation coefficient should be not less than 0.99. 
 Figure  1 (15)  linearity at 50% 
 
Figure 1 (16   )  linearity at 100% 
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                                          Figure 1 (17)   linearity at 150% 
 
 
 
 
 
TABLE 1.5  LINEARITY. 
LEVEL CONCENTRATION IN 
µg/ml 
PEAK  AREA 
25% 15.62 985504 
50% 31.25 2030094 
75% 46.88 3096294 
100% 62.50 4039967 
125% 78.13 5016528 
150% 93.75 5992094 
 
                           
 
 
 
 
 
 
 
                                                                                                                    Experimental Details 
 
Department Of Pharmaceutical Analysis, RVS College Of Pharmaceutical Sciences  Page 54 
 
                                 Calibration Curve for Carvedilol 
                                  
 
                                           
RESULT: 
The correlation coefficient is 0.999. 
PRECISION: 
a)REPEATABILITY: 
Prepare the standard and sample solutions.  Inject standard and sample preparations and 
record the chromatograms .Calculate the % content of carvedilol. 
ACCEPTANCE CRITERIA 
%  content of carvedilol should be in between 90.0 to 110.0 
% RSD should be not more than 2.0%.  
 
 
 
 
y = 64107x + 17850
R² = 0.999
0
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                                             TABLE 1.6  REPEATABILITY. 
SAMPLE Wt(mg) AREA % ASSAY 
1 1798.25 4123717 97.51 
2 1812.02 4117537 96.62 
3 1825.02 4174580 97.26 
4 1820.13 4152250 97.00 
5 1835.14 4175261 96.74 
6 1841.13 4193482 96.85 
  Average 96.99 
  SD 0.33 
  % RSD 0.34 
 
INTERMEDIATE  PRECISION  (RUGGEDNESS): 
Ruggedness of the method was verified by analysing the six samples of same batch which 
was used for method precision as per testing procedure .This study  was performed by 
different analyst using different instrument and different column on different day. calculated 
the percentage assay and percentage relative standard deviation for six assay results. 
ACCEPTANCE CRITERIA: 
a)  Content of carvedilol should be in between 90.0 to 110.0. 
b)  The %RSD between the average results of two analysts should be not more than 2.0% 
RESULT: 
The % RSD between the average results of two analysts is 0.77 
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TABLE 1.7  RUGGEDNESS. 
 
 
 
 
 
 
 
 
RESULT:   Percentage relative standard deviation value indicates an acceptable level of 
ruggedness of the analytical method for the determination of assay of carvedilol tablets. 
SYSTEM PRECISION:   Five replicate injections of standard solution were injected .The 
mean and percentage RSD  for the peak areas of carvedilol were calculated . 
ACCEPTANCE CRITERIA: 
The percentage  RSD for peak areas of carvedilol is not more than 2.0. 
           
                                                     FIG1 (18) SYSTEM PRECISION 
 
  
 
 
 
Sample No Percentage of assay(w/w) 
 Analyst-I Analyst-II 
1 99.4 99.0 
2 99.9 97.0 
3 100.5 97.4 
4 99.6 97.1 
5 99.4 98.9 
6 100.6 98.7 
Average 99.9 98.0 
%RSD 0.54 1.0 
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                                                    Fig 1(19) SYSTEM PRECISION 
 
                                                        Fig1 (20) SYSTEM PRECISION 
 
 
 
 
 
                                          TABLE 1.8  PRECISION . 
Sr.No. Peak areas 
1 4200402 
2 4186308 
3 4199120 
4 4184070 
5 4203797 
Mean 4194739 
% RSD 0.2 
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CONCLUSION: 
Percentage RSD values indicates an acceptable level of precision of the analytical method for 
the assay of carvedilol tablets. 
METHOD PRESCISION: 
Six samples of 25mg tablets were analysed as per test method . The percentage of assay and 
percentage RSD of six results were calculated. 
ACCEPTANCE CRITERIA: 
The percentage RSD for percentage assay from six samples is not more than 2.0. 
 TABLE 1.9  METHOD PRECISION. 
Sr. No Percentage assay 
1 99.0 
2 97.0 
3 97.4 
4 97.1 
5 98.9 
6 98.7 
mean 98.0 
% RSD 1.0 
 
CONCLUSION: 
Percentage RSD values indicates an acceptable level of precision of the analytical method for 
the assay of carvedilol tablets. 
ROBUSTNESS: 
Carry out the analysis, mentioned under deliberately modified conditions mentioned 
in the table 
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                     TABLE 1.10  CONDITIONS OF ROBUSTNESS. 
S.NO PARAMETERS NORMAL 
CONDTION 
HIGHER SIDE LOWER SIDE 
1 pH 3.0 3.2 2.8 
2 Flow rate 1.0ml/min 1.2ml/min 0.8ml/min 
3 wavelength 242nm 244nm 240nm 
 
ACCEPTANCE CRITERIA: 
% Content of carvedilol should be in between 90.0 to110.0. 
% RSD should be not more than 2.0%. 
PROCEDURE: 
Injected all the standard and sample preparations and recorded the chromatograms. 
Calculated  the % content of carvedilol.  
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TABLE 1.11  ROBUSTNESS. 
 
 
RESULT: 
% Content of carvedilol is 100.3%. 
% RSD is 0.23%. 
SOLUTION STABILITY: 
Stability of analytical solution was verified by analyzing the standard and filtered sample 
solution initially and also at different time intervals as mentioned below by storing in sample 
compartment of HPLC instrument at ambient condition. Calculated the cumulative 
percentage RSD for peak areas of carvedilol for  both the sample and standard solution. 
ACCEPTANCE CRITERIA: 
The cumulative percentage RSD for peak area is not more than 2.0 
                                            
SAMPLE TYPE %ASSAY 
Flow 0.8ml(spl-1) 100.5 
Flow0.8ml(spl-2) 100.4 
Flow1.2ml(spl-1) 100.8 
Flow1.2ml(spl-2) 100.2 
PH 2.8(spl-1) 100.5 
PH 2.8(spl-2) 100.1 
PH3.2(spl-1) 100.2 
PH 3.2(spl-2) 100.0 
240nm(spl-1) 100.2 
240nm(spl-2) 100.2 
244nm(spl-1) 100.3 
244nm(spl-2) 100.0 
Average 100.3 
SD 0.23 
% RSD 0.23 
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Figure 1(21) solution stability at 8 hour 
 
 
 
 
 
                                      
                                         Figure 1(22  )  solution stability at 16 hour 
                                   
                                               Figure 1(23)  solution stability at 24 hours 
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STANDARD SOLUTION:                                 
                                         TABLE 1.12  SOLUTION STABILITY. 
TIME(HOURS) PEAK AREA CUMULATIVE % RSD 
Initial 4211010  
4 4290684 1.3 
8 4240415 0.9 
12 4310783 1.1 
16 4399875 1.7 
20 4352040 1.6 
24 4338045 1.5 
 
SOLUTION STABILITY OF SAMPLE : 
            TABLE1.13  SOLUTION STABILITY OF SAMPLE SOLUTION. 
           TIME(HOURS)            PEAK AREA CUMULATIVE % RSD 
Initial 4172514 - 
4 4112804 1.0 
8 4177426 0.9 
12 4218648 1.0 
16 4232835 1.1 
20 4205063 1.0 
24 4228953 1.0 
 
CONCLUSION: 
The standard  and filtered sample solution stable up to 24 hours when stored at 
ambient condition. 
SUMMARY &CONCLUSION FOR ASSAY: 
RESULT:        The Result of the above study is tabulated as below. The test parameters meet 
the acceptance criteria .The method employed in this analysis of carvedilol tablets –Assay is 
validated. 
                                                                                                                    Experimental Details 
 
Department Of Pharmaceutical Analysis, RVS College Of Pharmaceutical Sciences  Page 63 
 
TABLE 2.14  SUMMARY &CONCLUSION FOR ASSAY: 
S.NO TEST ACCEPTANCE CRITERIA RESULT 
1 System 
suitability 
a. %RSD for std injection is NMT 2.0% 
 
b. Tailing  factor for carvedilol peak is NMT 2.5 
 
0.23 
 
1.5 
2 Specificity a. All individual peaks should be well        
separated. 
 
b. The interference of carvedilol peak 
(main peak )from the other peaks should be       
Nil. 
 
c. The carvedilol purity is NLT 0.99 
 
 
Complies 
3 Accuracy a. The % recovery is in between 95% and   
105%. 
 
b. The %RSD for all recovery values should be 
NMT 2%. 
 
98.1% and 102.7% 
0.64% 
 
4 Linearity The correlation co efficient should be NLT 0.99 
 
0.99 
5  
 
 
Precision 
a.  %Content of carvedilol should be in      
between  90.0 to 110.0 (Analyst 1). 
 
b.  %Content of carvedilol should be in 
between 90.0 to 110.0(Analyst 2) 
 
c.  %RSD not more than 2.0%(Analyst 1) 
 
d.  %RSD not more than 2.0% (Analyst 2) 
 
e.  The %RSD between the average results of 
two analysts should be not more than 2.0% 
99.9% 
 
 
98.0% 
 
 
0.54% 
 
1% 
 
0.77% 
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6  
Robustness 
a. % Content of carvedilol should be in   
between 90.0 to 110.0 
 
b. %RSD  not more than 2.0% 
100.3% 
 
0.23% 
 
7  
Solution 
stability 
 
 
 
 
 
 
 
 a.% RSD not more than 2.0% 
 
 
 
 
 
 
0.83% for standard 
 
0.64% for sample 
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METHOD DEVELOPMENT AND VALIDATION  FOR ESTIMATION OF 
CARVEDILOL IN TABLET DOSAGE FORM BY HPTLC 
METHOD DEVELOPMENT 
1. Selection of Mobile Phase: 
The selection of mobile phase was done by trial and error method in which several mobile 
phases were tried. The best mobile phase was selected based on the Rf value of the drugs. 
The mobile phase tried were listed below, 
1. Chloroform : Ethanol 
2.  Toluene: Ethyl Acetate: Methanol: Acetic  
3. Chloroform : toluene 
4. dichloromethane : methanol: toluene 
5. chloroform: methanol: toluene 
2. Fixed Mobile Phase: 
For carvedilol, chloroform: methanol: toluene (1.5: 3: 3.5 ) was selected as mobile 
Phase. 
   3.   Activation of Pre-Coated Plates: 
 Activated by placing in oven at110-120ºc for 30 minutes after sample spotting 
   4.  Sample Preparation: 
Preparation of Standard Stock Solution: 
The standard stock solutions of 1000 μg/ml of carvedilol were prepared by weighing 100mg 
of carvedilol dissolved with methanol in 100 ml volumetric flask and made up to the volume. 
  
 5. Application of Sample: 
Generally 0.1-0.5µl is most satisfactory for HPTLC application of the sample & standard as a 
band gives better separation, equal Rf values, and less spot broadening .The sample is applied 
a series of 0.1µl, 0.2µl, 0.3µl, 0.4µl & 0.5µl Standard of carvedilol solution were loaded as 
4mm band length in the 6 x 10 Silica gel 60F254 TLC plate using 100µl Hamilton syringe and 
CAMAG-LINOMAT-5 instrument. 
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6.  Spot Development : 
The Sample and standards loaded plate was kept in Twin trough chamber 10 x 10cm with 
respective mobile phase up to 15min for Chamber saturation.  After completion of chamber 
saturation, the plate was kept in mobile phase for development up to 90mm. 
7. Photo-Documentation: 
The developed plate was dried by hot-air to evaporate solvents from the plate and the plate 
was kept in Photo-documentation chamber.  The images of developed plate were captured at 
white light, UV 254nm and UV 366nm using CAMAG-REPROSTAR-3 instrument. 
8. Scanning: 
The developed plate was scanned in UV 254nm wavelength for carvedilol using CAMAG-
TLC SCANNER-3 instrument.  The Baseline display, Peak densitogram & Peak table of each 
track were obtained.  The carvedilol content present in the loaded sample was evaluated by 
Peak assignment with 5 level carvedilol standards.   
9. Spectrum scanning: 
The assigned peaks of standards and sample were scanned in spectrum of UV region (200nm-
400nm) and found the λmax value of carvedilol. 
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                                                            CHROMATOGRAMS 
Daylight before mobile phase run                       UV 366nm before mobile phase run 
 
 
 
                                    UV 254 nm before mobile phase run 
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Daylight after mobile phase run         UV 366nm after mobile phase run 
 
                                       
                                UV 254 nm after mobile phase run 
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10. Linearity: 
  Aliquots of 0.1-0.5 µg/spot of standard solution of carvedilol is applied on the 
plate and then developed and detected as earlier method. The calibration curves constructed 
with the concentration range must obey Beer’s law. The linearity was evaluated by regression 
analysis. The linearity of the drug was determined by calibration curves and the linearity 
based on the area observed for carvedilol. The regression co-efficient value for carvedilol is 
0.999 respectively.  The results are summarized in table 1. 
                                     TABLE 2.1 LINEARITY OF CARVEDILOL 
 
 
  
        
 
 
 
 
 
CALIBRATION CURVE FOR CARVEDILOL 
 
 
y = 6886.x + 23.76
R² = 0.999
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SL.No 
Standard concentration 
µg/ spot Peak Area 
1 0.1 756.35 
2 0.2 1387.96 
3 0.3 2081.94 
4 0.4 2775.92 
5 0.5 3469.9 
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                             Table 2 -2 Calibration Parameters for CARVEDILOL  
 
  Parameters 
 
CARVEDILOL 
Linearity Range(µg/Spot) 
 
0.1 – 0.5 
Slope 
 
                  6886 
Intercept                   23.76 
 
Regression Co-Efficient 
 
                  0.999 
 
                                                              Fig 2.1 Carvedilol Densitogram‐0. 1µg 
 
 
 
 
 
                                                                                                                   Experimental Details 
 
Department Of Pharmaceutical Analysis, RVS College Of Pharmaceutical Sciences  Page 71 
 
                                               Fig 2.2 Carvedilol Densitogram-0. 2µg 
 
                                                Fig 2.3 Carvedilol Densitogram‐0. 3µg 
   
                                                                                                                   Experimental Details 
 
Department Of Pharmaceutical Analysis, RVS College Of Pharmaceutical Sciences  Page 72 
 
                                                 Fig 2.4 Carvedilol Densitogram-0.4µg 
 
                                                  Fig 2.5 Carvedilol Densitogram – 0.5µg 
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OVERLINE SPECTRA 
 All colours except orange – Standard Carvedilol   ; orange mark - Sample 
3D display of Peak densitogram – All tracks (Carvedilol standards and sample) @ 
254nm 
 
 
ANALYSIS OF FORMULATION: 
Preparation of Sample Solution: 
 Twenty tablets were powdered and weighed equivalent to 100 mg of carvedilol which 
is transferred in to a100ml volumetric flask and extracted with methanol the extract was 
filtered through Whatman filter paper No.41 and residue washed with methanol and made up 
to 100ml with methanol. Aliquot of 0.3μl solution of tablet formulation were applied and 
plate was developed with mobile phase.  
Assay: 
 The sample solutions were spotted along with the standard to check the specificity. 
Spotted 0.3μl of sample solution allowed to develop in appropriate mobile phase and detect 
the spots as described earlier. From the peak area recorded the amount of the drug in the 
formulation was determined. 
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                                               Table 2-3 Analysis of Formulations 
S.No. Drug  
Label 
Claim(mg) 
Amount 
found  
(mg) 
Assay %RSD 
 
 
 
1. 
 
 
 
 
 
Carvedilol 
 
 
25 24.87 99.5 
 
                                             Fig 2.6 Carvedilol densitogram -Sample 
 METHOD VALIDATION:      
 1. Linearity: 
Aliquots of 0.1-0.5 µg/spot of standard solution of Carvedilol is applied on the plate with the 
help of micro liter syringe using an automatic sample applicator. The plates were developed, 
dried and scanned densitometrically at 254 nm. The drug peak-area was calculated for each 
concentration level and a graph was plotted of drug concentration against the peak area and 
shown in (Fig.3). Calibration parameters are given in table 2 : 5 
                                                  
                                                                                                                   Experimental Details 
 
Department Of Pharmaceutical Analysis, RVS College Of Pharmaceutical Sciences  Page 75 
 
                                           Table 2-4 Linearity of Carvedilol 
 
 
 
 
 
 
 
 
 
 
 
                                                         CALIBRATION CURVE OF CARVEDILOL 
 
 
                                            
                                          
    
 
 
 
 
y = 6886.x + 23.76
R² = 0.999
0
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Concentrationµg/ml
Linearity of carveilol
 
SL.No 
Standard 
concentration 
µg/ spot 
Peak Area Peak Height 
1 0.1        756.35 35.8 
2 0.2       1387.96 72.4 
3 0.3 2081.94 123.9 
4 0.4 2775.92 168.8 
5 0.5 3469.9 203.4 
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                            Table 2 -5 Calibration Parameters for  Carvedilol 
 
  Parameters 
 
Carvedilol 
Linearity Range(µg/Spot) 
 
                  0.1-0.5 
Slope 
 
                   6886 
Intercept                    23.76 
 
Regression Co-Efficient 
 
                   0.999 
 
2. Accuracy:  
Accuracy of the developed method was confirmed by doing a recovery study as per ICH 
guidelines at three different concentration levels (80%, 100% and 120%) by replicate analysis 
(n=3). Standard drug solutions were added to a preanalyzed sample solution, and then 
percentage of drug content was calculated. The results of the accuracy study are reported in 
Table 5. From the recovery study, it was clear that the method is very accurate for 
quantitative estimation of Carvedilol in tablet dosage form because all the statistical results 
were within the acceptance range (i.e., % RSD <2.0). 
Table 2 -6 Recovery studies for Carvedilol (n=3) 
 
Label claim 
(mg / tablet) 
 
Recovery level   
(%) 
 
Amount added 
(mg) 
 
Amount recovered 
(mg) ± % RSD 
 
% Recovery 
25 80 20 19.96±0.42 99.82 
25 100 25 24.65±0.85 98.67 
25 120 30 30.45±0.59 101.5 
 
3. Precision: 
The precision of the method (system reproducibility) was assessed by spotting 0.3µl of drug 
solution six times on a TLC plate, followed by development of plate and recording the peak 
area for 6 spots. The % RSD for peak area values of carvedilol was found to be 0.58. The 
results were shown in Table-7.  
             The method reproducibility (intra-day precision) was determined by analyzing 
standard solution in the concentration range of 0.1 µg/spot to 0.5 µg/spot of drug for 3 times 
on the same day and inter-day precision was determined by analysing corresponding 
standards daily for 3 day over a period of one week. The intra-day and inter-day coefficients 
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of variation (%RSD) are in range of 0.13 to .36 and 0.30 to 0.56, respectively. The results 
were shown in Table- 7a, 7b. 
                                       Table 2 – 7 Precision of Carvedilol 
 
S.No 
 
 
Concentration 
(µg/ spot) 
 
Peak Area 
1. 0.3 2081.94 
2. 0.3 2111.40 
3. 0.3 2090.52 
4. 0.3 2075.36 
5. 0.3 2087.25 
6. 0.3 2092.17 
 
Mean 
 
- 
 
2089.77 
 
Percentage Relative 
Standard Deviation 
 
- 
 
            0.58 
 
Table 2 – 7a Intra-day Precision of Carvedilol 
 
S.No Concentration 
(µg / spot) 
Area Mean Standard 
Deviation 
% RSD 
1. 
2. 
3. 
0.1 
0.1 
0.1 
756.35 
761.05 
754.50 
 
757.3 
 
 
3.37 
 
0.44 
1. 
2. 
3. 
0.3 
0.3 
0.3 
2080.50 
2083.72 
2078.25 
 
2080.82 
 
2.74 
 
0.13 
1. 
2. 
3. 
0.5 
0.5 
0.5 
3469.50 
3465.64 
3475.82 
 
3470.32 
 
5.13 
 
0.14 
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Table 2 – 7b Inter-day Precision of Carvedilol 
 
S.No Concentration 
(µg / spot) 
Area Mean Standard 
Deviation 
% RSD 
1. 
2. 
3. 
0.1 
0.1 
0.1 
757.98 
754.50 
762.35 
 
758.28 
 
 
3.93 
 
0.52 
1. 
2. 
3. 
0.3 
0.3 
0.3 
2081.94 
2090.50 
2078.25 
 
2083.56 
 
6.28 
 
0.30 
 
 
DISCUSSION:  
                    The proposed HPTLC analytical method for the quantification of carvedilol in 
tablet formulation is simple, accurate, rapid and can be employed for the routine analysis. 
Once the Rf value of the sample is determined, it requires only simple calculation. This 
method can be applied for the substances which obey Beer’s law. The low standard deviation 
and good percentage recovery indicated the reproducibility and accuracy of the method.  
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DEVELOPMENT OF UV SPECTROSCOPIC METHOD FOR THE 
QUANTIFICATION OF CARVEDILOL 
Carvedilol contains chromophore system which can absorb UV radiation which is the basis of 
developing an UV method for its estimation. 
AIM: 
To perform UV spectrophotometric analysis of carvedilol in bulk and pharmaceutical 
formulations. 
3.1 PRACTICAL REQUIREMENT : 
UV spectrophotometric analysis of carvedilol in bulk and pharmaceutical formulations was 
performed using a Shimadzu UV- 1700 double beam UV visible spectrophotometer with 1cm 
quartz cell. 
Name of the balance                           :   Sartorius- weighing range 20mg-200gm 
Name of the formulation  : Commercially available tablets of carvedilol                       
were procured from the local market and quantification performed. 
3.2 :  Reagent used      :   Methanol [A.R. Grade] Merck. 
SELECTION OF SOLVENTS: 
The UV spectrum of carvedilol was recorded in various solvents .The spectral pattern and 
absorbance maxima of carvedilol were thoroughly analysed. It was found that significant 
spectra of carvedilol appeared in methanol and this solvent was selected for determining 
carvedilol content in formulation by UV spectroscopic method. Stock solution of carvedilol 
was prepared by dissolving 100mg of drug in 100ml of methanol to obtain the concentration 
of 1000µg/ml. It was further diluted to obtain concentration ranging from 1-5µg/ml. 
2. SELECTION OF WAVELENGTH: 
The stock solution was suitably diluted with methanol, so as to contain 10µg/ml of carvedilol. 
This solution was scanned in the UV region and found that carvedilol exhibited maximum 
absorbance at about 242 nm .Hence 242 nm was selected for the proposed study. 
 
                                                                                                                    Experimental Details 
 
Department Of Pharmaceutical Analysis, RVS College Of Pharmaceutical Sciences  Page 80 
 
PREPARATION OF STANDARD CURVE : 
Adequate dilutions were made from stock solution to get a concentration ranging  from 1-
5µg/ml for carvedilol using methanol. Absorbance of these solutions were measured at 
242nm (Table3.1) .The measured absorbance was plotted against concentration .From the 
graph it was found that the Beer’s law concentration for carvedilol lies between 1 -5µg .The 
overlain spectra and the calibration graph are shown in fig ( 1). 
                                         Table3.1  Absorbance Of Carvedilol 
 
 
Concentration (µg/ml) Absorbance 
1 0.113 
2 0.220 
3 0.323 
4 0.433 
5 0.521 
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QUANTIFICATION OF CARVEDILOL IN FORMULATION : 
The average weight of 20 tablets of carvedilol was weighed .An aliquot quantity equivalent to 
100mg of carvedilol was weighed and transfered to 100ml volumetric flask. The contents 
were shaken with methanol, so as to dissolve the active ingredients and filtered .Then it was 
made upto the volume .It was further diluted to obtain the stock solution with a concentration 
50µg/ml. From this solution 3ml was taken and diluted to 50 ml to get a concentration of 
3µg/ml .The resultant solution was scanned in the wavelength range of 200-400nm and the 
absorbance was measured. The concentration of drug was determined by single point 
standardization method and results are shown in table1.2 
                                                           Ctest =   A test×C stnd  
                                                                              Astnd 
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                Table 3.2 Analysis of carvedilol formulation 
 
 
 
 
 
 
 
 
 
 
 
 
Drug 
 
Amount mg/tab 
 
%Label claim 
 
%RSD 
Label Found 
 
 
Carvedilol 
 
 
25 mg 
25.43 
25.4 
25.38 
25.45 
25.43 
25.4 
 
 
0.051 
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VALIDATION OF THE METHOD 
The developed method was validated in terms of linearity, accuracy and stability studies. 
1) Linearity 
Carvedilol was found to be linear in a concentration range of 1-5µg/ml. The absorbance of 
this solution were measured at 242 nm and a calibration graph was plotted using absorbances 
versus concentration.The correlation co-efficient value was found to be                        
0.998. 
                           CALIBRATION CURVE OF CARVEDILOL 
                                   
 
                                               
2)   Accuracy 
The accuracy,specificity, suitability and validity of the present method were satisfied by 
conducting percentage recovery studies. A known quantity of the drug was added to the pre-
analyzed sample formulation at 50% and 100% levels. The percentage recovery and standard 
deviation were calculated.(Table 3).    
The % recovery was calculated by using the following formula 
 
y = 0.104x + 0.006
R² = 0.998
0
0.1
0.2
0.3
0.4
0.5
0.6
0 1 2 3 4 5 6
A
bs
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nc
e
Concentration µg/ml
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%Recovery     =      Amount of drug                          Amount of drug 
                                found after addition         -         found in sample before 
                                of standard drug                          addition of standard drug     ×   100 
                                                  Amount of standard drug added                                                                          
                                              TABLE 3.3    RECOVERY STUDIES 
Drug Level Amount 
found in µg 
Actual amount 
Added  in µg 
 
%Recovery 
% RSD 
  
 
 
Carvedilol 
 
50% 
12.30 12.22 100.6  
0.12 12.28 12.22 100.4 
12.30 12.22 100.6 
 
100% 
24.71 24.64 100.3  
0.06 24.69 24.64 100.2 
24.70 24.64 100.2 
 
3)  Stability 
The drug solution was found to be stable for about three hours at room temperature. Stability 
data reported in table 4. 
TABLE 3.4 STABILITY DATA 
Concentration in µg/ml              Time (min)                 Absorbance 
 
 
                 1 
 
 
0 0.113 
30 0.110 
60 0.109 
90 0.117 
120 0.112 
150 0.107 
                     180                     0.108 
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                                              TABLE 3. 5 REPEATABILITY   STUDIES 
Concentration in µg/ml Absorbance               %RSD 
 
 
 
1 
0.117  
 
 
0.93 
0.118 
0.119 
0.117 
0.117 
0.116 
 
 
5 
0.516  
 
0.47 
0.513 
0.511 
0.510 
0.515 
0.511 
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                                                   TABLE  3. 6: INTER-DAY PRECISION 
  Concentration            
µg/ml) 
           Day Absorbance    %RSD 
 
 
 
                1 
 
 
1 0.116  
 
 
       1.02 
 
2 0.117 
3 0.115 
4 0.115 
5 0.116 
6 0.114 
 
 
 
5 
 
1 0.512  
 
       0.40 
2 0.513 
3 0.512 
4 0.516 
5 0.510 
                6 0.513 
 
 
                                           TABLE 3. 7 INTRA- DAY PRECISION 
Concentration µg/ml 6 times in a day Absorbance      %RSD 
 
 
 
1 
1 0.115  
 
 
         1.47 
 
 
2 0.113 
3 0.111 
4 0.114 
5 0.115 
6 0.112 
 
 
 
                5 
1 0.513  
 
 
         0.45 
2 0.515 
3 0.510 
4 0.512 
5 0.515 
6 0.516 
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 DISCUSSION 
The proposed UV analytical method for the quantification of carvedilol in tablet formulation 
is simple, accurate, and rapid and can be employed for the routine analysis. Once the 
absorbance of the sample is determined ,it requires only simple calculation .This method can 
be applied for the substances which obey Beer’s law. The low standard deviation and good 
percentage  recovery indicated the reproducibility  and accuracy of the method.  
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RESULTS AND DISCUSSION 
        Validated analytical methods are aimed for the estimation of carvedilol in formulation. 
Simple, precise, rapid, accurate methods were developed for the estimation of carvedilol in 
formulation by following methods. 
Estimation  of carvedilol by RP-HPLC. 
 Estimation of carvedilol by HPTLC. 
  Estimation  of carvedilol by UV-spectroscopy. 
   In RP-HPLC   method, a wavelength of 242 nm was selected and the mobile phase which 
consist potassium di hydrogen phosphate buffer : acetonitrile, in the ratio of (60:40).  pH 3 
adjusted with formic acid at a flow rate of 1ml/min were found to be optimum condition for 
analysis. The retention time was found to be 2.9 with optimized conditions. 
   Carvedilol showed the linearity in the range of 15.62 -93.75µg/ml. Where the peak shape 
was symmetrical and a good correlation coefficient value was obtained. 
    The percentage label claim and recovery at three different levels, 80%, 100%, 120%, level 
was carried out. The suitability of the method was thus proved. Precision of the method was 
studied by making repeated injection of the same sample and standard deviation was 
determined. Inter day and intra day precision was also carried out and % RSD was calculated. 
In HPTLC during the stage of method development different mobile phase were tried and 
mobile phase comprising of ethyl chloroform: methanol : toluene in the proportion of 1.5: 3: 
3.5 v/v/v for carvedilol , were found to be better and produced the Rf  value of 0.72 for 
carvedilol. 
     The linearity of drug was determined by calibration curve and the linearity based on the 
area observed in the range of 0.1 – 0.5 µg/ ml. 
      The regression coefficient value for carvedilol is 0.999. Interday precision of the drugs 
was studied. No interference with the additives of the formulation was reported .Recovery 
studies were carried out for the accuracy parameter and were reported . 
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   The validated method was applied for the analysis of tablet containing 25 mg carvedilol 
drug as the label claim.  The method developed was simple. It has showed a good peak and 
good Rf  values.  
 In case of UV-spectroscopic method solubility is the important parameter. Solubility 
parameter was studied and methanol was selected as the solvent, since it gave a maximum 
absorbance and a good spectral pattern when compared with other solvents. The linearity was 
found to be in the range of 1 -5 µg/ml at the maximum absorbance of 242 nm. The marketed 
formulation was extracted and diluted to get the concentration in the linearity range. The 
solution was scanned and measured at 242 nm. Percentage recovery, linearity, stability 
studies were also carried out. The above method gave a satisfactory recovery values and 
found to be stable, linear, hence it can be used for routine analysis of the drug formulation. 
These methods, RP-HPLC, HPTLC, UV spectroscopy were found to be sensitive, precise, 
and accurate. However these three methods can be used for the routine analysis of carvedilol 
from formulation.  
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                                                      CONCLUSION 
In order to develop a RP-HPLC, HPTLC, UV effective most of the effect should be spent in 
method development and optimization as this will improve the final method performance. A 
well developed method should be easy to validate. A method should be developed with the 
goal to analyse rapidly, the preclinical samples, formulations and commercial samples. 
       Review of literature on drug strongly indicates that there is few method available for  
determination and validation of carvedilol in bulk and pharmaceutical dosage forms . 
Keeping in this mind we developed methods for determination and validation of carvedilol in 
bulk and pharmaceutical dosage forms by RP- HPLC, HPTLC, UV methods with some 
improvements than the existing methods. 
      The analytical procedure described for assay was specific, linear, precise, accurate, and 
system suitable for determination of carvedilol in bulk and pharmaceutical dosage forms. 
The observations of the validation parameters such as accuracy, precision, specificity, 
linearity, shows that the developed methods can be employed for routine analysis of bulk and 
tablets form of carvedilol.  The result obtained from the validation parameters met the ICH 
and USP   requirement   as well as obeys BEER’S law.    
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